Holdings (Monthly)
Guide ↗
iShares Neuroscience and Healthcare ETF
· iShares Trust| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | 066922519 | Apr 2024 | 650,078 | $650K | 13.30% | STIV |
| 2 | Praxis Precision Medicines Inc | 74006W207 | Jan 2026 | 782 | $246K | 5.02% | EC |
| 3 | AXSOME THERAPEUTICS, INC. | 05464T104 | Jan 2026 | 1,299 | $239K | 4.90% | EC |
| 4 | ALKERMES PUBLIC LIMITED COMPANY | G01767105 | Jan 2026 | 6,568 | $223K | 4.55% | EC |
| 5 | BIOGEN INC. | 09062X103 | Apr 2024 | 1,069 | $192K | 3.93% | EC |
| 6 | Scholar Rock Holding Corp | 80706P103 | Apr 2024 | 4,306 | $191K | 3.91% | EC |
| 7 | PTC THERAPEUTICS, INC. | 69366J200 | Apr 2024 | 2,510 | $190K | 3.88% | EC |
| 8 | Denali Therapeutics Inc | 24823R105 | Jan 2026 | 8,338 | $181K | 3.71% | EC |
| 9 | argenx SE | 04016X101 | Apr 2024 | 215 | $181K | 3.70% | — |
| 10 | ACADIA PHARMACEUTICALS INC. | 004225108 | Apr 2024 | 7,065 | $178K | 3.63% | EC |
| 11 | Xenon Pharmaceuticals Inc | 98420N105 | Apr 2024 | 4,307 | $177K | 3.61% | EC |
| 12 | CATALYST PHARMACEUTICALS, INC. | 14888U101 | Apr 2024 | 7,110 | $173K | 3.53% | EC |
| 13 | NEUROCRINE BIOSCIENCES, INC. | 64125C109 | Apr 2024 | 1,247 | $170K | 3.47% | EC |
| 14 | SUPERNUS PHARMACEUTICALS, INC. | 868459108 | Apr 2024 | 3,493 | $168K | 3.44% | EC |
| 15 | CENTESSA PHARMACEUTICALS PLC | 152309100 | Jan 2026 | 6,159 | $151K | 3.10% | — |
| 16 | SK Biopharmaceuticals Co Ltd | Y806MN108 | Jan 2026 | 1,801 | $147K | 3.01% | EC |
| 17 | Edgewise Therapeutics Inc | 28036F105 | Apr 2024 | 4,897 | $138K | 2.82% | EC |
| 18 | AVADEL PHARMACEUTICALS PUBLIC LIMITED COMPANY | G29687103 | Jan 2026 | 5,990 | $129K | 2.64% | EC |
| 19 | SAREPTA THERAPEUTICS, INC. | 803607100 | Apr 2024 | 6,336 | $129K | 2.64% | EC |
| 20 | Dyne Therapeutics Inc | 26818M108 | Apr 2024 | 6,733 | $120K | 2.46% | EC |
| 21 | Dianthus Therapeutics Inc | 252828108 | Apr 2024 | 2,253 | $120K | 2.46% | EC |
| 22 | H. LUNDBECK A/S | N/A | Jan 2026 | 17,155 | $115K | 2.35% | EC |
| 23 | AxoGen, Inc. | 05463X106 | Apr 2024 | 2,885 | $101K | 2.06% | EC |
| 24 | BioArctic AB | N/A | Jan 2026 | 2,484 | $89K | 1.82% | EC |
| 25 | Biohaven Ltd | G1110E107 | Jan 2026 | 6,937 | $82K | 1.68% | EC |
| 26 | Neuren Pharmaceuticals Ltd | N/A | Jan 2026 | 6,950 | $80K | 1.65% | EC |
| 27 | Taysha Gene Therapies Inc | 877619106 | Jan 2026 | 14,326 | $65K | 1.32% | EC |
| 28 | Dynavox Group AB | N/A | Jan 2026 | 6,211 | $61K | 1.24% | EC |
| 29 | Capricor Therapeutics Inc | 14070B309 | Apr 2024 | 2,579 | $56K | 1.15% | EC |
| 30 | Idorsia Ltd | N/A | Jan 2026 | 10,661 | $51K | 1.03% | EC |
| 31 | Annexon Inc | 03589W102 | Apr 2024 | 7,887 | $49K | 1.01% | EC |
| 32 | Rapport Therapeutics Inc | 75383L102 | Jan 2026 | 1,804 | $48K | 0.98% | EC |
| 33 | INTEGRA LIFESCIENCES HOLDINGS CORPORATION | 457985208 | Apr 2024 | 4,227 | $47K | 0.96% | EC |
| 34 | SanBio Company Limited | N/A | Jan 2026 | 3,700 | $44K | 0.90% | EC |
| 35 | Zylox-Tonbridge Medical Technology Co Ltd | N/A | Jan 2026 | 12,500 | $40K | 0.81% | EC |
| 36 | Bright Minds Biosciences Inc | 10919W405 | Jan 2026 | 500 | $39K | 0.80% | EC |
| 37 | Medincell SA | N/A | Jan 2026 | 1,318 | $35K | 0.72% | EC |
| 38 | Fulcrum Therapeutics Inc | 359616109 | Jan 2026 | 3,080 | $33K | 0.68% | EC |
| 39 | Regenxbio Inc | 75901B107 | Jan 2026 | 2,960 | $33K | 0.68% | EC |
| 40 | MicroPort NeuroScientific Corp | N/A | Jan 2026 | 20,000 | $30K | 0.62% | EC |
| 41 | Ceribell Inc | 15678C102 | Jan 2026 | 1,418 | $29K | 0.60% | EC |
| 42 | Anavex Life Sciences Corp | 032797300 | Apr 2024 | 5,784 | $27K | 0.56% | EC |
| 43 | VANDA PHARMACEUTICALS INC. | 921659108 | Apr 2024 | 3,517 | $27K | 0.54% | EC |
| 44 | Benitec Biopharma Inc | 08205P209 | Jan 2026 | 2,096 | $26K | 0.52% | EC |
| 45 | Neuropace Inc | 641288105 | Apr 2024 | 1,634 | $25K | 0.51% | EC |
| 46 | PEIJIA MEDICAL LIMITED | G6981F109 | Jan 2026 | 29,000 | $25K | 0.50% | EC |
| 47 | Prothena Corporation PLC | G72800108 | Jan 2026 | 2,784 | $25K | 0.50% | EC |
| 48 | Solid Biosciences Inc | 83422E204 | Apr 2024 | 3,717 | $24K | 0.49% | EC |
| 49 | Oncolys Biopharma Inc | J61461109 | Jan 2026 | 1,800 | $20K | 0.41% | EC |
| 50 | Clearpoint Neuro Inc | 18507C103 | Jan 2026 | 1,550 | $20K | 0.41% | EC |
| 51 | Entrada Therapeutics Inc | 29384C108 | Apr 2024 | 1,390 | $16K | 0.33% | EC |
| 52 | NEUROGENE INC. | 64135M105 | Jan 2026 | 856 | $15K | 0.31% | EC |
| 53 | TONIX PHARMACEUTICALS HOLDING CORP. | 890260839 | Jan 2026 | 755 | $13K | 0.27% | EC |
| 54 | Larimar Therapeutics Inc | 517125100 | Apr 2024 | 3,323 | $12K | 0.24% | EC |
| 55 | SANGAMO THERAPEUTICS, INC. | 800677106 | Jan 2026 | 21,371 | $11K | 0.23% | EC |
| 56 | Voyager Therapeutics Inc | 92915B106 | Apr 2024 | 2,794 | $11K | 0.22% | EC |
| 57 | Alector Inc | 014442107 | Apr 2024 | 4,362 | $8K | 0.17% | EC |
| 58 | Cognition Therapeutics Inc | 19243B102 | Jan 2026 | 5,385 | $6K | 0.12% | EC |
| 59 | CASSAVA SCIENCES, INC. | 14817C107 | Apr 2024 | 2,457 | $5K | 0.10% | EC |
| 60 | BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agency Shares | 066922477 | Jan 2026 | 1,674 | $2K | 0.03% | STIV |
| 61 | JAPANESE YEN | N/A | Jan 2026 | 149,531 | $966 | 0.02% | — |
| 62 | SWISS FRANC | N/A | Jan 2026 | 743 | $962 | 0.02% | — |
| 63 | KOREAN WON | N/A | Jan 2026 | 1,337,671 | $929 | 0.02% | — |
| 64 | EURO | N/A | Jan 2026 | 753 | $893 | 0.02% | — |
| 65 | DANISH KRONER | N/A | Jan 2026 | 5,043 | $800 | 0.02% | — |
| 66 | AUSTRALIAN DOLLAR | N/A | Jan 2026 | 729 | $508 | 0.01% | — |
| 67 | SWEDISH KRONE | N/A | Jan 2026 | 2,498 | $280 | 0.01% | — |
| 68 | HONG KONG DOLLAR | N/A | Jan 2026 | 1,359 | $174 | 0.00% | — |